Nzussouo Ndahwouh Talla, Kadjo Herve Adje, Coulibaly Daouda, Ekaza Euloge, Kouakou Bertin, N'Golo David Coulibaly, Tempia Stefano, Davis Richard, Dosso Mireille, Thompson Mark
Influenza Division, U.S. Centers for Disease Control and Prevention (CDC), South Africa.
Global Disease Detection and Response Program/U.S.-Naval Medical Research Unit-3 (NAMRU-3), South Africa.
Afr J Infect Dis. 2013 Aug 9;7(2):31-35. doi: 10.4314/ajid.v7i2.3.
Detection of circulating influenza strains is a key public health concern especially in limited-resource settings where diagnosis capabilities remain a challenge. As part of multi-site surveillance in Côte d'Ivoire during the 2009 influenza A(H1N1) pandemic, we had the opportunity to test respiratory specimens collected from patients with acute respiratory illness (ARI). We analyzed and compared the percentage of specimens testing positive using three laboratory methods (rtRT-PCR, ELISA, viral culture). From January to October 2009, 1,356 respiratory specimens were collected from patients with acute respiratory illness and shipped at the WHO NIC (Institut Pasteur) Cote d'Ivoire, and 453 (33%) tested positive for influenza by one or more laboratory methods. The proportion of positive influenza tests did not differ by the sex or age of the patient or presenting symptoms, but did differ depending on the timing and site of specimen collection. Of the 453 positive specimens, 424 (93.6%) were detected by PCR, 199 (43.9%) by ELISA and 40 (8.8%) by viral culture. While seasonal influenza A(H1N1) virus strains were prominent, only four 2009 pandemic influenza A(H1N1) cases were detected. Use of molecular biology method (rtRT-PCR) increased sensitivity and diagnosis capabilities. Among all three methods used, rRT-PCR was the most sensitive and rapid method. More capacity building is still required for viral culture. Need to collect denominator data in order to have an accurate estimate of the burden of influenza. There was delayed introduction of pandemic influenza A(H1N1)2009 in Cote d'Ivoire.
检测循环流感毒株是一项关键的公共卫生问题,在资源有限、诊断能力仍具挑战的环境中尤为如此。作为2009年甲型H1N1流感大流行期间科特迪瓦多地点监测的一部分,我们有机会对从急性呼吸道疾病(ARI)患者采集的呼吸道标本进行检测。我们分析并比较了使用三种实验室方法(逆转录实时荧光定量PCR、酶联免疫吸附测定、病毒培养)检测呈阳性的标本百分比。2009年1月至10月,从急性呼吸道疾病患者采集了1356份呼吸道标本,并运往世卫组织科特迪瓦国家流感中心(巴斯德研究所),其中453份(33%)通过一种或多种实验室方法检测出流感呈阳性。流感检测呈阳性的比例在患者的性别、年龄或呈现的症状方面没有差异,但因标本采集的时间和地点而异。在453份阳性标本中,424份(93.6%)通过PCR检测出,199份(43.9%)通过酶联免疫吸附测定检测出,40份(8.8%)通过病毒培养检测出。虽然季节性甲型H1N1流感病毒株很突出,但仅检测到4例2009年甲型H1N1流感大流行病例。使用分子生物学方法(逆转录实时荧光定量PCR)提高了敏感性和诊断能力。在所使用的三种方法中,逆转录实时荧光定量PCR是最敏感、最快速的方法。病毒培养仍需要更多能力建设。需要收集分母数据以便准确估计流感负担。2009年甲型H1N1流感大流行在科特迪瓦出现延迟。